At Comm Corporation – Trademark Portfolio
Entity Type: 03
At Comm Corporation holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include XIOX, @COMM, COMMVIEW, COMMVIEW PLUS, and COMMVIEW CLOUD. The owner is based in San Leandro, CA.
907 Burkhart Ave
San Leandro, CA 94579
Showing of trademarks Trademarks
Trademark Classifications
At Comm Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does At Comm Corporation have?
At Comm Corporation has 12 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned, 2 cancelled.
What trademark classes does At Comm Corporation file in?
At Comm Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are At Comm Corporation's most well-known trademarks?
At Comm Corporation's registered trademark portfolio includes well-known marks such as XIOX, @COMM, COMMVIEW, COMMVIEW PLUS, and COMMVIEW CLOUD. These are among 7 currently registered trademarks in the portfolio.
What is At Comm Corporation's trademark registration success rate?
At Comm Corporation has a 58% trademark registration rate, with 7 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.